3billion has received CAP accreditation on November 15th. CAP accreditation is an evaluation system by the College of American Pathologists, an organization of clinical pathologists in the United States. This accreditation officially signifies that the quality of our rare disease diagnostic services meets global standards.

3billion currently provides services to more than 200 institutions in 46 countries. The accreditation will serve as an important stepping stone for 3billion's overseas market expansion and its growth into a global leader in rare disease diagnosis.

Original article: Medigate News. 쓰리빌리언, 희귀질환 유전자검사 미국 임상병리학회 인증 획득